ARCHIVES

The Line Item for Cancer Centers and SPOREs to Remain Flat, Near $598 Million for the 2013 Fiscal Year

This article is from The Cancer Letter archive.

Vol. 38 No. 16 | April 20, 2012

Download PDF Visit The Full Archive

Related Articles

ACS Initiates Cage In Approach to Study Of alternative Methods

June 18, 1993

ColoPrint Improves Prognosis In Stage II and III Colon Cancer

January 28, 2011

In Brief: Judge Rules FDA Modernization Act Violates First Amendment Over Publications Policy

August 6, 1999

SmithKline Seeks FDA Action Against Homeopathic Smoking-Cessation Gum

March 6, 1998

Guest Editorial: Anil Potti Hires “Online Reputation Managers” As Journals Retract His Biomarker Research

April 15, 2011

Cancer Information Available By Fax

May 3, 1991